Recent CDC data show that that wastewater SARS-CoV-2 detections are high and that LP.8.1 and related strains XFG and NB.1.8.1 ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

US biotech firm Moderna (Nasdaq: MRNA) shares rose by over 4% on Tuesday to close at $24.84 (£18.2) despite US equity indexes ...

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the ...

Preliminary results from an ongoing Phase IV trial showed that Moderna’s updated 2025-2026 Spikevax vaccine generated a ...

In a major development, AHIP (formerly America's Health Insurance Plans), the insurance company trade group, announced that ...

The World Health Organisation claims their roll-out prevented 14.4 million deaths worldwide in their first year, with some ...

Teams are getting leaner and flatter, while leaders at the top are overseeing more than ever before. Everyone, everywhere is ...

With confusion about eligibility for COVID-19 vaccines, Gov. Gretchen Whitmer is expected to sign an executive directive ...

U.S. health insurers represented by America’s Health Insurance Plans pledge to cover CDC-recommended COVID and flu vaccines ...

Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an AI-focused startup raised its second ‘megaround.’ ...

Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.